
New research is “decoding the link” between the nucleotide excision repair protein XPC and lung cancer susceptibility in the setting of cigarette smoke exposure and may help illuminate the mechanisms of DNA damage, repair, and carcinogenesis in lung cancer.
A team from the Indiana University School of Medicine conducted the research and presented their findings during the American Thoracic Society 2024 International Conference. They explained the rationale behind the research, noting that “despite the known mutagenicity of cigarette smoke, only 10% to 15% of smokers will develop lung cancer in their lifetimes,” meaning “what determines a smoker’s susceptibility to lung cancer is poorly understood.”
The researchers identified the nucleotide excision repair protein XPC as a tumor suppressor “that may contribute to lung tumorigenesis when mutated and combined with cigarette smoke.” They hypothesized that cigarette smoke, combined with XPC knockdown, would cause genomic instability that activates the DNA damage response and increases the frequency of micronuclei and nuclear aberrancies.